REG - CIP Merchant Capital IXICO plc - Further investment in Ixico plc

IXICOAnnouncement

15/06/2021 07:05

RNS Number : 8669B
  
CIP Merchant Capital Ltd
  
15 June 2021
  
 

15 June 2021
 
CIP MERCHANT CAPITAL LIMITED
("CIP" or the "Company")
 
Further investment in Ixico plc
 
CIP is pleased to announce that, further to its announcement of 15 April 2021, it has acquired a further 150,000 ordinary shares of 1p each in Ixico plc (AIM: IXI) ("Ixico"), the artificial intelligence data analytics company delivering insights in neuroscience, for a total consideration of approximately £0.12 million.
 
Accordingly, CIP is now interested in, in aggregate, 3,374,500 ordinary shares of Ixico, representing approximately 7.03 per cent. of Ixico's issued share capital.
 
For the six month period ended 31 March 2021, Ixico achieved revenue of £4.9 million, gross profit of £3.3 million and a net profit attributable to its equity holders of £0.84 million. As at 31 March 2021, Ixico had cash and cash equivalents of £7.01 million and net assets of £10.39 million.
 
 
 
For further information, please contact:
 



Merchant Capital Manager Limited (Investment Manager)
Wikus Van Schalkwyk
 


+44 1481 749363




Strand Hanson Limited (Nominated Adviser and Broker) 
James Bellman / Matthew Chandler / Ritchie Balmer


+44 20 7409 3494



 
 
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ACQUSVRRAWUNAUR